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Abstract
Introduction
King’s College Hospital criteria are currently used to select liver transplant candidates in acet-
aminophen-related acute liver failure (ALF). Although widely accepted, they show a poor sen-
sitivity in predicting pre-transplant mortality and cannot predict the outcome after surgery. In
this study we aimed to develop a new prognostic score that can allow patient selection for liver
transplantation more appropriately and identify patients at high risk of futile transplantation.
Methods
We analysed consecutive patients admitted to the Royal Free and Beaujon Hospitals
between 1990 and 2015. Clinical and laboratory data at admission were collected. Predic-
tors of 3-month mortality in the non-transplanted patients admitted to the Royal Free Hospi-
tal were used to develop the new score, which was then validated against the Beaujon
cohort. The Beaujon-transplanted group was also used to assess the ability of the new
score in identifying patients at high risk of transplant futility.
Results
152 patients were included of who 44 were transplanted. SOFA, CLIF-C OF and CLIF-
ACLF scores were the best predictors of 3-month mortality among non-transplanted
patients. CLIF-C OF score and high dosages of norepinephrine requirement were the only
significant predictors of 3-month mortality in the non-transplanted patients, and therefore
were included in the ALF-OFs score. In non-transplanted patients, ALF-OFs showed good
performance in both exploratory (AUC = 0.89; sensitivity = 82.6%; specificity = 89.5%) and
the validation cohort (AUC = 0.988; sensitivity = 100%; specificity = 92.3%). ALF-OFs score
was also able to identify patients at high risk of transplant futility (AUC = 0.917; sensitivity =
100%; specificity = 79.2%).
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Conclusion
ALF-OFs is a new prognostic score in acetaminophen-related ALF that can predict both the
need for liver transplant and high risk of transplant futility, improving candidate selection for
liver transplantation.
Introduction
Acetaminophen overdose (APAP-OD) is the most frequent cause of acute liver failure (ALF)
in Western countries[1]. ALF is a life-threatening condition characterized by rapid severe liver
injury and hepatic encephalopathy in patients without pre-existing liver disease. The clinical
presentation is characterized by abnormal liver biochemical values, coagulopathy, decline in
mental function, peripheral vasodilatation, features of the systemic inflammatory response
syndrome and ultimately multi-organ failure (MOF) [2]. The period of active injury in acet-
aminophen overdose can be self-limiting and displays a hyperacute pattern in majority of
patients; most of them recover with medical management alone including N-acetyl cysteine
[3]. However, in patients who continue to deteriorate, an emergency liver transplantation (LT)
is the only life-saving option and survival is inversely related to the time period elapsed
between listing and the procurement of an organ.
The decision-making process for LT is currently based upon the King’s College Hospital
criteria (KCH), which includes a set of parameters dedicated specifically to acetaminophen-
induced ALF [4,5]. However, in a recent meta-analysis, KCH criteria, while showing a specific-
ity of 95%, was associated with a very poor sensitivity (58%) in predicting LT-free mortality[6].
Several alternative prognostic scores have been developed with the aim to optimise sensitivity
further while retaining specificity [7–9]. In addition to the difficulties faced with accurately
identifying suitable LT candidates in ALF, it is important to recognise that the LT procedure
itself is associated with high peri- and post-operative mortality and long-term complications,
and requires life-long treatment with immunosuppression [10]. In the context of organ short-
ages and potential complications of LT, it is imperative that determining suitability of LT in
ALF patients should also take in to account the probability of survival after LT in order to opti-
mize organ allocation thus avoiding “futile” transplantation.
The primary aim of this study was to develop a prognostic score that would accurately pre-
dict the 3-month mortality in acetaminophen induced ALF (with or without LT) thus avoiding
futile emergency LTs. Four different assessment strategies were used to address this hypothe-
sis: 1) study best predictors of poor prognosis amongst the commonly used current scoring
systems applied to patients with critical liver diseases; 2) to develop a new score using the best
existing scores and additional clinical and biochemical variables, and validate its prognostic
accuracy in an external cohort; 3) to characterize the pre-transplant features that may indicate
high risk of futile LT; 4) to validate the accuracy of the new score in predicting futility of LT in
an independent cohort.
Patient and methods
Study population and statistical analysis
We analysed all consecutive patients admitted with acetaminophen related ALF between 1990
and 2015 to the Intensive care unit of Royal Free Hospital (RFH), London (United Kingdom)
and to the Liver Intensive Care Unit of Beaujon Hospital (BJH), Clichy (France). ALF was
defined as the presence of severe liver injury with onset of hepatic encephalopathy (HE) within
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12 weeks of the first symptoms[11]. Patients with pre-existing liver disease were excluded.
Clinical and laboratory data were collected at the time of admission as well as the use of
mechanical ventilation support, vasopressors and continuous renal replacement therapy.
The study endpoint was all-cause mortality during the first 3 months after the admission.
Patients were listed for liver transplantation according to KCH criteria [4] (the modified ver-
sion including lactate levels was applied from 2002)[5]. Data for this study was obtained
through archived patient notes in the hospital and the follow up data retrieved through a com-
bination of follow up clinic notes, patient’s general physicians and direct telephone contact
with patients themselves. This database is updated at regular intervals and has been analysed
for other purposes previously. The research and development department at the Royal Free
Hospital where this project was undertaken, have defined the study as a clinical audit and ser-
vice evaluation project with no requirement for formal ethics approval. The data was fully
anonymised and the need for consent was waived by the R&D department.
Continuous parametric variables were expressed as mean ± standard deviation and were
compared using Student t-test. Non-parametric variables were showed as median and range,
and compared with Kruskal-Wallis Test. Categorical variables were compared using the Chi-
squared test. SPSS software package (version 20.0, SPSS Inc., Chicago, Ill, United States) and
Medcalc1 (version14.8.1, MedCalc Software bvba) were used for statistical analysis.
Performance of existing scores
The principal liver-specific and general intensive care scores were calculated at time of admis-
sion. Those who received an emergency liver transplant (LT) were analysed separately from
non-transplant (NOLT) patients. The KCH criteria were considered met in APAP-OD pa-
tients with pH<7.3 or lactate>3.5mmol/L following adequate resuscitation or the presence of
following three features: international normalized ratio of Protrombin time (INR)>6.5, serum
creatinine>3.4 mg/dl and a grade 3 or 4 hepatic encephalopathy based on West Haven criteria
[12]. The Chronic Liver Failure Consortium Organ failure score (CLIF-C OF), with a range
from 0 to 18, evaluates the failure of six organ systems (liver, kidney, brain, coagulation, circu-
lation and respiratory system) taking into account the serum bilirubin, serum creatinine, INR,
mean arterial blood pressure, PaO2 and fractional inspired concentration of oxygen (FiO2),
PaO2/FiO2 ratio and the use of renal replacement therapy, vasopressors and invasive mechani-
cal ventilation. Chronic Liver Failure Consortium Acute on Chronic Liver Failure (CLIF-C
ACLF) score (range 0 to 100) is based on CLIF-C OF score incorporating additional variables
of age and white blood cells count. Both scores were calculated using the CLIF research plat-
form (www.clifresearch.com) to provide an estimate of the number of failed organs, the clini-
cal severity, and the probability of death in the short and long-term follow up [13]. Model for
end stage liver disease (MELD) score is based on total bilirubin, INR and serum creatinine and
was calculated as 9.6 x log creatinine (mg/dL) + 3.8 x log bilirubin (mg/dL) + 11.2 x log INR
+ 6.43[14]. United Kingdom model for end-stage liver disease (UKELD) is a variant of MELD
that include serum sodium [15] and is currently used to allocate organs in United Kingdom’s
liver transplant list. The Sepsis-related Organ Failure Assessment (SOFA) provides an assess-
ment of six organ systems: liver, renal, coagulation, cardiovascular, respiratory and central
nervous system, the composite score ranging from 0 to 22 calculated on a 5 point grading
scale (0 to 4) for each organ system [16]. Acute Physiology, Age, Chronic health Evaluation
(APACHE) 2 (range 0–71) utilises the age of the patient, chronic health status, and a number
of acute physiological variables including the worst value during the first 24 Hours of the heart
rate, mean blood pressure, temperature, respiratory rate, PaO2, Alveolar-arterial gradient of
Oxygen, haematocrit, white blood cells count, serum creatinine, presence of acute kidney
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failure, sodium, pH and Glasgow Coma Scale (GCS), [17]. APACHE 3 (range 0 to>299), addi-
tionally, also includes urine output, urea, glucose, total bilirubin, PaCO2 and a different grad-
ing of GCS parameters [18]. ROC curve analysis was used to assess the performance of
prognostic scores to predict 3-month mortality. The cut-off was identified by Youden index
and its Hazard Ratio (HR) was identified by Cox regression analysis. The Area Under the
Curve (AUC), sensitivity, specificity, along with positive predictive value (PPV) and negative
predicting value (NPV) and p value were determined.
Developing a new score
The training cohort included NOLT patients admitted to RFH after 2001, the year that coin-
cided with Norepinephrine as the preferred vasopressor of choice used in this setting. Multi-
variate Cox regression analysis was used to identify predictors of mortality between the first
three best scores obtained from the previous analysis and the variables that were not part of
them and resulted in significant association with mortality in univariate analysis. The factors
showing a p<0.05 were used to develop the new score as follows: (regression coefficient β1) x
(variable 1) + (regression coefficient β2) x (variable 2) + (regression coefficient β3) x (variable
3) + etc. The ability to predict the mortality of the new model was assessed and compared with
the existing scores by ROC analysis. The new score was validated in the cohort of non-trans-
planted patients from BJH.
Predictors of high risk of futility of LT
Patients from Beaujon hospital were used as explorative cohort. Futile LT was defined as
occurrence of death within 48 hours of surgery in the context of development of MOF and/or
irreversible brain damage but without major surgical complications (hepatic artery thrombo-
sis, portal vein thrombosis, outflow obstruction, haemorrhagic shock) and/or primary graft
non-function. The “non futile transplantation” included those who survived for at least 48 hrs
following LT, and the deaths beyond this period were the direct result of transplant complica-
tions. Clinical and laboratory variables at the time of admission were analysed by Cox regres-
sion to identify the predictors of futility. The ability of the new score to predict futility was
tested using ROC analysis.
Results
Baseline patients’ characteristics
152 patients admitted with acetaminophen related ALF were included in this study. As shown
in Fig 1, 126 (82.9%) patients met the KCH criteria. Of them, 71 (56.3%) were listed for an
emergency LT: 18 (25.4%) died on the waiting list, 9 (12.7%) improved without an LT and 44
(61.9%) were transplanted. (Fig 1). The mortality rate after 3 month from the hospitalization
was 27.3%. Despite meeting the indication for an emergency LT, 18 (32.7%) were considered
too sick to receive LT, 10 (18.2%) had psychiatric contraindication and 27 (49.1%) recovered
spontaneously. Among patients who did not fulfil KCH criteria (n = 26/152, 17.1%), 6 (23.1%)
were listed for LT: 3 were transplanted and survived at 3 months, while the other 3 improved
and were removed from the waiting list. Of the 20 patients who did not fulfil KCH criteria and
were not listed, only 1 died after 5 days due to MOF. As shown in Table 1, 98 patients were
admitted to RFH and 54 to BJH. There were no differences between the two cohorts regarding
the age, gender, 3-month mortality and fulfilment of KCH criteria during hospitalization (S1
Table).
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However, more patients in the BJH cohort received LT than in RFH (51.9% vs 19.4%;
p<0.001) and the median time to death from admission was significantly shorter (1 vs 8 days;
p = 0.002). The BJH cohort also showed higher levels of serum ammonia (300 vs 98 umol/L;
p<0.001), lactate (8.6 vs 4.8 mmol/L; p = 0.009) and norepinephrine requirement (15 vs 0
mcg/min; p = 0.004). No statistically significant differences were seen in the grade of HE and
the use of organ support therapy in the first 24 hours of hospitalization.
Performance of existing scores
We analysed the 98 patients admitted in the intensive care unit of RFH. The mean age was
37.6±13.4 years and 66.3% were female. 64.3% presented with severe grades (3/4) of hepatic
encephalopathy. An emergency LT was performed in 19/98 (19.3%) patients, all of them had
met the King’s College Hospital criteria. Of 79 NOLT patients, 13 were listed but did not
receive a LT. Eight of them (61.5%) died on the waiting list and 5 (38.5%) spontaneously recov-
ered. Of the 66 patients not listed, 16 (24.2%) did not fulfil KCH criteria; the remaining 50
patients met KCH criteria but LT was contraindicated in 15 patients (22.7%) who were too
sick to receive an LT and 10 (15.2%) patients had psychiatric contraindication; 25 recovered
spontaneously. As shown in Table 2, significantly higher number of LT patients needed
mechanical ventilation (89.5% vs 62%; p = 0.022) than NOLT patients. The 3-month mortality
rate was 37.8% and there was no difference between transplanted and non-transplanted
patients (LT 36.8%, NOLT 39.2%, p = 0.847). All of death within 3 months among NOLT
patients were due to MOF and only the 22.6% had culture-positive sepsis. In transplant
patients 5 (71.4%) died due to sepsis, 1 (14.3%) due to MOF without sepsis and 1 (14.3%) com-
mitted suicide after 88 days from liver transplant. The survival time between the admission
and death was significantly longer in the LT group (34 (5–92) vs 5.5 (0–21) days; p<0.001).
The median MELD score and mean CLIF-C ACLF score were significantly higher in the LT
cohort.
As shown in Table 3, in the NOLT cohort, all of the scores calculated at the time of admis-
sion had statistically significant ROC values. The KCH criteria had the lowest AUC (0.638)
and the lowest PPV (49%) and prediction of poor outcome (the 3-month mortality) associated
with a sensitivity of 83.9% and specificity of 43.7%. The highest sensitivity (100%) belonged to
Fig 1. Flow chart of patients’ outcome in the study. Patients were first divided according to whether they
fulfilled or not KCH criteria and therefore were listed or not for liver transplantation. Reasons for liver
transplant ineligibility and the outcome of the different categories were reported. ALF: Acute Liver Failure;
KCH: Kings College criteria.
https://doi.org/10.1371/journal.pone.0188151.g001
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APACHE 3 but it was associated with the lowest specificity (41.6%) that resulted in an AUC of
0.740. The best score was SOFA with an AUC of 0.799 followed by CLIF-C OF (0.793) and
CLIF-C ACLF (0.762). CLIF-C OF showed a higher sensitivity than SOFA (93.5% vs 77.4%)
and a lower specificity (58.3% vs 70.8%). There was no significant difference between these
two AUCs (p = 0.849) and all of them were significantly higher when compared to KCH AUC
(SOFA vs KCH p = 0.009; CLIF-C OF vs KCH p = 0.012). SOFA cut-off (11) was associated
with a HR of 5.2 obtained by Cox univariate analysis (95% I.C. 2.13–12.73; p<0.001) and
showed a PPV of 63.1% and a NPV of 82.9%. Patients with a CLIF-C OF score higher than the
cut off (12) had a 38.9-fold increase in mortality risk (95% I.C. 1.66–907.57, p = 0.023). The
CLIF-OF positive predictive value was 59.1% and the chance of a patient to survive with a
CLIF-C OF score less than 12 (NPV) at the admission was 93.2%. In the LT group none of the
scores calculated at the time of admission had statistically significant at ROC values in predict-
ing the 3-month mortality from admission.
Table 1. Baseline characteristics of population study.
RFH (n = 98) BJH (n = 54) p value
Age (years) 37.6 ±13.4 39.3 ±13.4 NS
Sex (Female) 65 66.3% 35 64.8% NS
KCH (yes) 83 84.7% 43 79.6% NS
LT 19 19.4% 28 51.9% <0.001
3-months mortality 38 38.8% 18 33.3% NS
Days to death from admission 8 0–92 1 0–52 0.002
Grade HE 3–4 63 64.3% 36 66.7% NS
Vasopressor use 60 61.2% 26 48.1% NS
Renal replacement therapy 61 62.2% 31 57.4% NS
Mechanical ventilation 66 67.3% 29 53.7% NS
Body temperature (˚C) 36.5 31–39.2 36.9 32.9–39.0 NS
Heart rate (bpm) 120 32–165 110 60–160 0.003
Mean arterial pressure (mmHg) 63 43–97 73 35–123 0.002
PCO2 (kPa) 4.5 2–8.7 3.9 1.3–6.0 <0.001
PaO2 (kPa) 13.8 6.3–36.7 15.4 6.9–35.3 NS
FiO2 (%) 30 21–100 21 21–100 NS
PaO2/FiO2 (kPa) 50 12.8–110.2 53 8.3–151 NS
A-a Gradient (mmHg) 65.1 -79.2–563.2 39.2 -88.3–636 NS
Norepinephrine dose (mcg/min) 0.0 0–130 15 0–265.6 0.004
Ammonia (umol/L) 98 35–286 300 50–999 <0.001
Platelets (10^9/L) 80.5 6–288 121.5 9–461 <0.001
Creatinine (umol/L) 226.5 43–825 145.5 49–564 NS
Urea (mmol/L) 8 1.8–46.9 5.7 1.2–17.8 0.005
Total Bilirubin (umol/L) 88 3–581 67.5 8–492 NS
INR 8 1.2–16 6.9 2.2–11.9 NS
pH 7.34 6.93–7.51 7.36 6.92–7.52 NS
Sodium (mmol/L) 129.8 ± 7.22 136.7 ±6.21 NS
HCO3 (mmol/L) 19.1 ±5.22 15.6 ±5.80 NS
Lactate (mmol/L) 4.8 0.8–35.8 8.6 1.1–24.9 0.009
Variables are expressed as numbers and percentages or mean ± standard deviation (or median and range when appropriate). KCH, King’s College Hospital
criteria; LT, liver transplantation; HE, hepatic encephalopathy; INR, international normalized ratio.
https://doi.org/10.1371/journal.pone.0188151.t001
A new prognostic score for patients with acute liver failure
PLOS ONE | https://doi.org/10.1371/journal.pone.0188151 December 5, 2017 6 / 14
Table 2. Comparison between not-transplanted (NOLT) and transplanted (LT) patients (RFH cohort).
NOLT (n = 79) LT (n = 19) p value
Age (years) 39.2 ±13.6 31.4 ±11.0 NS
Sex (Female) 49 62.0% 16 84.2% NS
KCH (yes) 64 81.0% 19 100% 0.039
3-month mortality 31 39.2% 7 36.8% NS
Days to death from admission 5.5 0–21 34 5–92 <0.001
Grade HE 3–4 51 64.6% 12 63.2% NS
Vasopressor use 46 58.2% 14 73.7% NS
Renal replacement therapy 48 60.8% 13 68.4% NS
Mechanical ventilation 49 62.0% 17 89.5% 0.022
MELD 33.8 8–44 36.6 29–43 0.002
UKELD 70 45–82 71 63–81 NS
APACHE 2 23 ±8.76 27.6 ±7.16 NS
APACHE 3 125 ±32.2 140 ±27.9 NS
SOFA 11 3–20 12 3–20 NS
CLIF-C OF 13 9–17 14 10–17 NS
CLIF-C ACLF 51.2 ±13.4 54.7 ±6.81 0.029
Variables are expressed as numbers and percentages or mean ± standard deviation (or median and range when appropriate).
KCH, King’s College Hospital criteria; HE, hepatic encephalopathy; MELD, model for end-stage liver disease; UKELD, United Kingdom model for end-stage
liver disease; APACHE, acute physiology in chronic health evaluation; SOFA, Sequential organ failure assessment; CLIF-C OF, Chronic liver failure-
consortium organ failures; CLIF-C ACLF, Chronic liver failure-consortium acute on chronic liver failure.
https://doi.org/10.1371/journal.pone.0188151.t002
Table 3. Performance of main prognostic scores in predicting 3-month mortality in not-transplanted (NOLT) and transplanted (LT) patients (RFH
cohort).
NOLT AUC p cut-off HR Sensitivity Specificity PPV NPV
MELD 0.671 0.007 33.4 2.595 74.2 54.2 51.1 76.5
UKELD 0.674 0.006 71 2.127 54.8 72.9 56.5 71.4
APACHE 2 0.757 <0.001 18 13.572 96.8 45.8 53.5 95.6
APACHE 3 0.740 <0.001 101 35.870 100 41.6 52.4 100
SOFA 0.799 <0.001 11 5.2 77.4 70.8 63.1 82.9
KCH 0.638 0.005 y 3.28 83.9 43.7 49 80.8
CLIF-C OF 0.793 <0.001 12 38.914 93.5 58.3 59.1 93.2
CLIF-C ACLF 0.762 <0.001 46 9.059 93.5 52.1 55.7 92.5
LT AUC p cut-off HR Sensitivity Specificity PPV NPV
MELD 0.564 NS 40.7 2.952 33.3 100 100 76.4
UKELD 0.724 NS 74 0.298 100 38.5 42.8 100
APACHE 2 0.558 NS 32 3.093 50 84.6 59.9 78.5
APACHE 3 0.557 NS 140 2.305 66.6 69.2 49.9 81.7
SOFA 0.532 NS 9 0.69 33.3 92.3 66.6 74.9
KCH 0.628 NS n 0.409 33.3 92.3 66.6 74.9
CLIF-C OF 0.577 NS 16 0.513 100 15.4 35.3 100
CLIF-C ACLF 0.660 NS 60 0.386 100 38.5 42.8 100
AUC: area under the curve; HR, hazard ratio; PPV, positive predictive value; NPV, negative predictive value; MELD, model for end-stage liver disease;
UKELD, United Kingdom model for end-stage liver disease; APACHE, acute physiology in chronic health evaluation; SOFA, Sequential organ failure
assessment; CLIF-C OF, Chronic liver failure-consortium organ failures; CLIF-C ACLF, Chronic liver failure-consortium acute on chronic liver failure.
https://doi.org/10.1371/journal.pone.0188151.t003
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Developing the new score
Sixty-one consecutive patients admitted from 2001 at RFH comprised the exploratory cohort.
The mortality rate after 3 months from hospital admission was 37.7%. Among the predictors
of mortality identified in the univariate analysis (S2 Table), GCS, mean arterial pressure,
pCO2, FiO2, platelets and INR and the use of vasopressor and mechanical ventilation were
excluded from the multivariate since they were part of the best three scores obtained from the
previous analysis. As reported in Table 4, the following factors were significant at univariate
analysis and then included in multivariate Cox regression: body temperature, heart rate, alveo-
lar-arterial gradient, dose of Norepinephrine, platelet count, albumin, aPTT, pH, potassium,
base excess, SOFA, CLIF-C OF and CLIF-C ACLF. The variables significantly associated with
3-month mortality were CLIF-C OF (p = 0.014; B = 0.391; HR = 1.478; 95%IC 1.08–2.02) and
the dose of norepinephrine required to maintain mean arterial pressure >70 mmHg
(p = 0.012; B = 0.020; HR = 1.021; 95%CI 1.00–1.04).
The new score was calculated by multiplying the value of the predictors to their regression
coefficient beta (B) and adding the results together
Acute liver failure-Organ failure score (ALF-OFs) = (CLIF-C OF x 0.391)+(Norepineph-
rine mcg/min x 0.020). ALF-OFs was tested in the exploratory cohort and ranged between
5.2 and 11.3. In ROC analysis its AUC (0.890) was significantly higher when compared with
CLIF-C OF (p = 0.044) and KCH (p<0.0001). The best cut-off was 5.58 characterized by a sensi-
tivity of 82.6%, a negative predictive value of 89.5% and the highest specificity (89.5%) and PPV
(82.6%) among the five tested scores (Fig 2A). As showed in Kaplan-Meier curve (Fig 2B), there
was a significant difference in the 3-month mortality when dividing the patients according to
the ALF-OFs score cut-off of 5.58 (>5.58 = 67.9% vs<5.58 = 12.1%; p<0.001). The validation
cohort was composed of 26 non-transplanted patients admitted at BJH. 13/26 (50%) died within
3 months from the hospitalisation due to MOF. As showed in Fig 2B, ALF-OFs achieved an
AUC of 0.988 with a sensitivity of 100% and a specificity of 92.3% at ROC analysis. Its curve
was also significantly higher (p = 0.0013) when compared to KCH’s AUC (0.731).
Risk of futile LT
We analysed 28 patients from BJH who received an emergency LT for acetaminophen-related
ALF. Of them, 4 (14.3%) died within 3 days from the theatre due to a MOF and without any
Table 4. Cox regression analysis of pre-transplant variables associated with 3-month mortality in not-transplanted group.
Alive Dead Multivariate
38 23 p B HR 95% CI
Body temperature 37.0 32–39 35.0 32–39 0.539 0.131 1.14 0.75–1.73
Heart rate (bpm) 105 32–150 130 100–160 0.050 0.023 1.02 1.00–1.05
A-a Gradient (mmHg) 39.55 -57–524 157.3 -79–563 0.765 -0.01 0.99 0.99–1.00
Norepinephrine dose (mcg/min) 0.00 0–37 21.33 0–130 0.012 0.020 1.02 1.00–1.04
Albumin (g/L) 28 ± 6.17 21 ± 4.66 0.851 -0.01 0.99 0.91–1.08
APTT (sec) 43 27–101 80 30–250 0.963 0 1 0.99–1.02
pH 7.387 ± 0.96 7.270 ± 0.15 0.505 -1.57 0.21 0.00–21.2
Potassium (mmol/L) 3.4 2.3–5.2 3.6 3.0–5.6 0.328 -0.48 0.62 0.24–1.62
BE (mmol/L) -3 ± 5.86 -9.2 ± 6.64 0.268 -0.04 0.95 0.87–1.04
Lactate (mmol/L) 3.8 0.8–14.6 8.8 2.6–20.3 0.620 -0.03 0.96 0.83–1.12
SOFA 8.5 ± 3.55 13.5 ± 3.01 0.762 -0.04 0.96 0.71–1.28
CLIF-C OF 11.5 9–16 15 12–16 0.014 0.391 1.48 1.08–2.02
CLIF-C ACLF 45.3 ± 14.3 58.7 ± 9.3 0.248 -0.03 0.97 0.91–1.03
https://doi.org/10.1371/journal.pone.0188151.t004
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surgical complication. We considered them in the group that was at high risk of futility. We
included in the non-futile group 24 patients that were still alive after 1 month from the liver
transplant. All of the patients that died early required a multiorgan support treatment since
hospital admission. They showed higher heart rate (114 vs 106bpm; p = 0.022), lower PaO2/
FiO2 rates (14.9 vs 69.1kPa; p = 0.043) and required significant higher doses of Norepinephrine
(68.1 vs 0 mcg/min; p = 0.035) (Table 5).
ALF-OFs was significantly higher in those that died early on univariate Cox regression
(p = 0.021, Hazard Ratio 2.955, 95% CI 1.18–7.40). At ROC analysis (Fig 3), the new score
achieved an AUC of 0.917 (p<0.0001). The best cut-off was 6.5 with a 100% of sensitivity and
79.2% of specificity (PPV = 44.5%; NPV = 100%). Fig 3.
Discussion
KCH criteria [5] have been extensively used to identify patients who need an emergency LT.
However, recent meta-analyses showed that KCH had poor sensitivity in predicting both the
LT-free mortality [6,19] and the outcome after liver transplantation [8,20]. Several attempts
have been made to create new prognostic models [8,21–23]. However, most of them have
underestimated the role of multiple-organ failure in the context of ALF [24]. The drastic organ
shortage dictates that candidates for LT should be selected taking into account both the risk of
death with medical management alone and the probability of survival after transplantation.
This study aimed to develop a new prognostic score that could predict the 3-month mortality
in patients with acetaminophen induced ALF and at the same time identify the patients in
whom an emergency liver transplant at high risk of futility. Two cohorts from distinct inten-
sive care units comprised our study population. They were similarly matched for age, sex, HE
grade at presentation and need for organ support. The overall 3-month mortality rate in
NOLT and LT cohort were similar between the two centres and in line with the currently avail-
able literature [25–27]. However, the percentage of patients who fulfilled poor prognostic
Fig 2. ALF OFs score characteristics. (a) ROC curves for ALF-OFs, CLIF-C OF and KCH for 3-month mortality in not-transplanted patients. (b) Kaplan
Meier curve of ALF-OFs score for 3-month mortality in not-transplanted patients.
https://doi.org/10.1371/journal.pone.0188151.g002
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Table 5. Comparison between patients who died within 48 hours after LT and those that survived.
Dead at 48 hours (n = 4) Alive at 48 hours (n = 24) P value
Age (years) 45.7 ± 11.2 36.3 ± 11.6 NS
Sex (F) 3 75% 16 66.7% NS
Grade HE 3–4 4 100% 19 79.2% NS
Vasopressor use 4 100% 9 37.5% 0.020
Renal replacement therapy 4 100% 13 54.2% NS
Mechanical ventilation 4 100% 13 54.2% NS
Body temperature (˚C) 36.9 34–38.1 36.9 32.9–38.5 NS
Heart rate (bpm) 114 ± 37 106 ± 21.1 0.022
Mean arterial pressure (mmHg) 79 ± 31.2 78 ± 17.8 NS
PaO2/FiO2 (kPa) 14.9 ± 7.4 69.1 ± 41.5 0.043
Norepinephrine dose (mcg/min) 68.1 33.2–265.6 0 0–132.8 0.035
Ammonia (umol/L) 318 ± 247 389 ± 275 NS
Platelets (10^9/L) 156 ± 80 131 ± 78.2 NS
Creatinine (umol/L) 193 ± 81 189 ± 117 NS
Urea (mmol/L) 8.43 ± 5.29 6.13 ± 3.33 NS
Total Bilirubin (umol/L) 119 28–259 65 8–492 NS
INR 7.8 3.1–10 6.3 2.2–10 NS
pH 7.25 ± 0.12 7.33 ± 0.12 NS
Sodium (mmol/L) 144 138–154 137 129–148 NS
HCO3 (mmol/L) 16.5 ± 6.25 15.78 ± 6.22 NS
Lactate (mmol/L) 10.64 ± 4.51 8.97 ± 6.56 NS
ALF-OFs score 8 6.9–12 5.1 3.5–8.5 0.005
Variables are expressed as numbers and percentages or mean ± standard deviation (or median and range when appropriate). HE, hepatic encephalopathy;
INR, international normalized ratio; ALF-OFs, acute liver failure-organ failures.
https://doi.org/10.1371/journal.pone.0188151.t005
Fig 3. ROC curves for ALF-OFs, CLIF-C OF and KCH for patients at high risk of futility following liver
transplantation.
https://doi.org/10.1371/journal.pone.0188151.g003
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criteria and were listed for LT that was higher in BJH group. It might be due to a different
approach between the two centers. These potential differences may be due to the following rea-
sons. First, in RFH group the predominant reasons for no-listing despite fulfilling KCH crite-
ria were non-liver contraindications for liver transplantation. Second, in London the approach
was to stabilize the patients before the surgery. Therefore, patients who improved with a con-
servative therapy were removed from the waiting list. Moreover, patients that deteriorated
showing evidence of multiorgan failure and a poor response to treatment were not listed or, if
listed, removed from the waiting list because the benefit of liver transplantation was consid-
ered too low. This policy could also explain the absence of futile liver transplantion in the
Royal Free group. Third, the high proportion of patients considered too sick to be listed might
also be due to a late referral to RFH, London. Indeed, most of them had sepsis at the admis-
sion. KCH criteria were used to select LT candidates in both cohorts. However, only one third
of patients fulfilling the KCH were transplanted. Therefore, NOLT group was generated
including four different categories: patients that did not fulfil KCH, those who died while on
waiting list, those who improved spontaneously and those who were not listed for clinical or
psychiatric reasons. This cohort was characterized by a wide range of ALF severity and it could
be considered a reliable population for the creation of a new prognostic model. As the first
step, we tested the performance of the main prognostic scores used in hepatology and intensive
care units to predict the 3-month mortality in patients receiving LT or not. Among NOLT
group, the scores that explore the severity of MOF, such as SOFA, CLIF-OF and CLIF-ACLF,
showed the best AUCs. These results highlight the important prognostic role of hemodynamic
dysfunction even in the early stage of ALF[24,28]. On the other hand, none of the scores calcu-
lated at admission was able to predict the 3-month mortality in LT patients, confirming that
post-LT outcome is strongly affected by multiple factors including immunosuppression and
graft characteristics [29]. The second step in our strategy was to look for independent predic-
tors of 3-month transplant-free mortality. Since survival in patients with ALF has significantly
improved after year 2000 due to the advances in critical medical care[29–31], we decided to
analyse only patients admitted after this time point. The multivariate analysis included the
scores with the best performance (SOFA, CLIF-OF and CLIF-ACLF) along with the variables
tested significant in the univariate analysis and that were not present in these scores. CLIF-C
OF score and the level of requirements for norepinephrine were the only significant predictors
and therefore were used to build the new score. ALF-OFs score resulted a modified version of
CLIF-C OF where a greater importance is given to the cardiovascular dysfunction that has
been shown to significantly affect ALF patients’ outcome[24]. This could explain why our new
model performs better than the existing score with a good balance between sensitivity and
specificity both in the exploratory and validation cohorts.
The last step of our study consisted of identifying the predictors of patients at high risk of
early mortality after liver transplantation. Previously published studies have shown that survival
after liver transplantation for ALF is still lower compared to other aetiologies, indicating that a
better understanding of poor prognostic factors is mandatory to optimize organ allocation. No
consensus exists on the definition of criteria that defines futility of LT[30]. The three large stud-
ies, that explored the outcome after an emergency LT, did not analyse the different aetiology
(APAP-OD vs. non APAP-OD) separately and they did not discriminate patients according to
cause of death [10,29,32]. We decided to focus on the highest risk group defining a high risk of
futile LT as the occurrence of death within 48 hours due to MOF or irreversible brain damage
that were not related to graft-function, immunosuppression and surgical complication. This
definition allowed us to identify those patients in whom an emergency LT did not provide a
clinical benefit. Our findings showed that early deaths after LT were characterized by a greater
pre-transplant circulatory dysfunction, as suggested by the higher requirement of vasopressor
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in this group. ALF-OFs showed a good performance also in predicting the futility characterized
by a high sensitivity (100%) associated with an acceptable specificity (79.2%). Moreover ALF-
OFs allowed us to stratify the mortality risk in APAP-OD-ALF. Given the relatively small num-
ber of patients in this part of the study, we suggest caution in applying these criteria without fur-
ther validation to clinical practice. In conclusion, as shown in Fig 4, we identified two different
cut-offs that allowed us to further classify the patients into three categories; patients who are
likely to survive without a LT (ALF-OFs<4.5); patients with a high risk to die without a LT
(ALF-OFs 4.5–8.5); and those where a LT is at high risk of being futile (ALF-OFs>8.5). We
acknowledge that the numbers of patients are limited and larger studies are needed to further
investigate this topic. However, this study points to the role of multiple organs in defining the
outcome of ALF patients and describes a new prognostic score based on pre-LT variables to
define the need for LT and early post LT mortality.
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